CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The RESPONSE project seeks to revolutionize breast cancer treatment by using Hyperpolarized Magnetic Resonance imaging to detect non-responders to chemotherapy early in the treatment cycle. This approach aims to personalize therapy, improving patient outcomes and reducing unnecessary side effects.
Breast cancer is the prominent cancer among women globally, with over 2 million women diagnosed annually.
Even though early detection and advancements in treatment have led to improved outcomes and survival rates, still, 685,000 women died in 2020.
It is thus fundamental to select the best treatment for the individual patient (precision medicine) to improve outcome and reduce side effects (personalized healthcare).
The challenge is that predicting how well a patient responds to the therapy takes…
TECHNICAL UNIVERSITY OF DENMARK DTU
DANMARKS TEKNISKE UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Denmark, FREDERIKSBERG
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Israel, Jerusalem
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
UNIVERSITÄTSKLINIKUM SCHLESWIG-HOLSTEIN
Germany, Lübeck
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Kiel
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
